BMO Capital on Structure Therapeutics (GPCR): 'Licensing agreement with Genentech is not the large Pharma partnership that some Structure owners have been anxiously awaiting' Jan 6, 2026 04:25AM
Structure Therapeutics closes $747.5 million public offering Dec 11, 2025 04:01PM
Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs Dec 11, 2025 04:01PM
Structure Therapeutics prices $650 million public offering Dec 9, 2025 11:15PM
Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants Dec 9, 2025 11:15PM


Dec 9, 2025 04:41AM Structure Therapeutics (GPCR) PT Raised to $130 at BMO Capital
Dec 8, 2025 04:01PM Structure Therapeutics announces $500 million public offering
Dec 8, 2025 04:01PM Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants
Nov 20, 2025 04:07AM BMO Capital Reiterates Outperform Rating on Structure Therapeutics (GPCR)
Nov 10, 2025 08:05AM BMO Capital on Structure Therapeutics (GPCR): 'Year-End Readout Sets Key Inflection Point'
Nov 18, 2024 02:10PM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Oct 21, 2024 07:57AM BMO Capital Reiterates Outperform Rating on Structure Therapeutics (GPCR)
Jun 26, 2024 04:00PM BMO Capital Reiterates Outperform Rating on Structure Therapeutics (GPCR)
Jun 7, 2024 04:05PM Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
Jun 7, 2024 07:39AM BMO Capital Reiterates Outperform Rating on Structure Therapeutics (GPCR)
Jun 5, 2024 08:03PM Structure Therapeutics (GPCR) Announces Pricing of Upsized $476 Million Public Offering
Jun 5, 2024 07:53PM Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
Jun 3, 2024 04:09PM Structure Therapeutics (GPCR) Announces Proposed Share and Warrant Offering
Jun 3, 2024 04:09PM Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants
Apr 23, 2024 02:54PM BMO Capital Reiterates Outperform Rating on Structure Therapeutics (GPCR)
Oct 2, 2023 04:17PM Structure Therapeutics (GPCR) PT More Than Doubled to $83 at BMO Capital
Aug 2, 2023 02:08PM BMO Capital on Structure Therapeutics (GPCR): '"Today's weakness is an attractive entry point into 4Q23'
Feb 28, 2023 04:42AM BMO Capital Starts Structure Therapeutics (GPCR) at Outperform
Feb 7, 2023 04:00PM Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
Feb 7, 2023 04:00PM Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
Feb 3, 2023 05:53AM Structure Therapeutics (GPCR) Prices Upsized 10.74M ADS IPO at $15/ADS
Feb 2, 2023 07:41PM Structure Therapeutics Announces Pricing of Upsized Initial Public Offering
Feb 2, 2023 07:41PM Structure Therapeutics Announces Pricing of Upsized Initial Public Offering